Altered hematopoiesis in murine sickle cell disease

Blood

Volumn 94, Issue 4, 1999, Pages 1451-1459

  Blouin, Marie José ^a   De Paepe, Monique E ^a   Trudel, Marie ^a,b  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ERYTHROPOIESIS; HEMATOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SICKLE CELL ANEMIA; TRANSGENIC MOUSE;

EID: 0033566713     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.4.1451.416k02_1451_1459     Document Type: Article

References (43)

1. Watson J: A study of sickling of young erythrocytes in sickle cell anemia. Blood 3:465, 1948
2. Diggs LW, Bibb J: Erythrocyte in sickle cell anemia; morphology, size, hemoglobin content, fragility and sedimentation rate. JAMA 112:695, 1939
3. Diggs JV: Anatomic lesions in sickle cell disease, in Abramson H, Bertles JF, Wethers DL (eds): Sickle Cell Disease: Diagnosis, Management, Education, and Research. St Louis, MO, Mosby, CV, 1973, p 189
4. Grasso JA, Sullivan AL, Sullivan LW: Ultrastructural studies of the bone marrow in sickle cell anaemia. II. The morphology of erythropoietic cells and their response to deoxygenation in vitro. Br J Haematol 31:381, 1975
5. Perlingeiro RC, Costa FF, Saad ST, Queiroz ML: Early circulating erythroid progenitor cells and expression of erythropoietin receptors in sickle cell disease. Eur J Haematol 60:226, 1998
6. Beuzard Y, Tulliez M, Testa U, Vainchenker W, Dubart A, Tsapis A, Galacteros F, Breton-Gorius J, Rosa J: Beta-thalassemia and sickle cell disease in culture of early erythroid precursors: Hemoglobin synthesis and ultrastructural study. Blood Cells 7:179, 1981
7. Alter BP, He L, Acosta R, Knobloch ME, Thomson JC, Giardina P, Weinberg RS: Sickle and thalassemic erythroid progenitor cells are different from normal. Hemoglobin 16:447, 1992
8. Mankad VN, Baliga S, Phillips K, Shah AK, Yang YM: Relationship of burst-forming-unit-erythroid progenitors and their DNA-synthesis stage to fetal hemoglobin levels in hydroxyurea-treated patients with sickle cell anemia. Am J Hematol 46:259, 1994
9. Croizat H: Early circulating erythroid progenitors (BFU-E) in sickle cell anemia. Experientia 49:118, 1993
10. Reese AL, Altay C, Headlee ME, Gardiner MB, Webber B, Jonah F, Wilson JB, Huisman TH: The percentages of Hb F and of G gamma and A gamma chains in the Hb F synthesized by reticulocytes and BFUe-derived colonies of patients with sickle cell anemia. Hemoglobin 6:369, 1982
11. Papayannopoulou T, Nakamoto B, Buckley J, Kurachi S, Nute PE, Stamatoyannopoulos G: Erythroid progenitors circulating in the blood of adult individuals produce fetal hemoglobin in culture. Science 199:1349, 1978
12. West TB, Ohene-Frempong K, Stoeckert CJJ, Surrey S: Erythroid progenitors in the peripheral blood of children with sickle cell disease. Am J Pediatr Hematol Oncol 16:116, 1994
13. Popp RA, Popp DM, Shinpock SG, Yang MY, Mural JG, Aguinaga MP, Kopsombut P, Roa PD, Turner EA, Rubin EM: A transgenic mouse model of hemoglobin S Antilles disease. Blood 89:4204, 1997
14. Fabry ME, Sengupta A, Suzuka SM, Costantini F, Rubin EM, Hofrichter J, Christoph G, Manci E, Culberson D, Factor SM, Nagel RL: A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity. Blood 86:2419, 1995
15. Paszty C, Brion CM, Manci E, Witkowska HE, Stevens ME, Mohandas N, Rubin EM: Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science 278:876, 1997
16. Ryan TM, Ciavatta DJ, Townes TM: Knockout-transgenic mouse model of sickle cell disease. Science 278:873, 1997
17. Trudel M, Saadane N, Garel M-C, Bardakdjian-Michau J, Blouquit Y, Guerquin-Kern J-L, Rouyer-Fessard P, Vidaud D, Pachnis A, Romeo P-H, Beuzard Y, Costantini F: Towards a transgenic mouse model of sickle cell disease: Hemoglobin SAD. EMBO J 10:3157, 1991
18. Trudel M, De Paepe ME, Chretien N, Saadane N, Jacmain J, Sorette M, Hoang T, Beuzard Y: Sickle cell disease of transgenic SAD mice. Blood 84:3189, 1994
19. Skow LC, Burkhart BA, Johnson FM, Popp RA, Popp DM: A mouse model for beta-thalassemia. Cell 34:1043, 1983
20. De Paepe ME, Trudel M: The transgenic SAD mouse: A model of human sickle cell glomerulopathy. Kidney Int 46:1337, 1994
21. Grasso JA, Sullivan AL, Sullivan LW: Ultrastructural studies of the bone marrow in sickle cell anaemia. I. The structure of sickled erythrocytes and reticulocytes and their phagocytic destruction. Br J Haematol 31:135, 1975
22. Peters SO, Kittler ELW, Ramshaw HS, Quesenberry PJ: Ex vivo expansion of murine cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 87:30, 1996
23. Hogan B, Costantini F, Lacy E: Manipulating the Mouse Embryo. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1986, p 17
24. Castoldi GL: Erythrocytes, in Zucker-Franklin D, Greaves MF, Grossi CE, Marmont AM (eds): Atlas of Blood Cells. Function and Pathology. Philadelphia, PA, Lea and Febiger, 1981, p 36
25. Berman I: The ultrastructure of erythroblastic islands and reticular cells in mouse bone marrow. J Ultrastruct Res 17:291, 1967
26. Guyton AC, Hall JE (eds): Textbook of Medical Physiology. Philadelphia, PA, Saunders, 1996, p 513
27. Harris JW, Murphy JR: Life cycle of sickle cells in circulation, in Abramson H, Bertles JF, Wethers D (eds): Sickle Cell Disease, Diagnosis, Management, Education, and Research. St Louis, MO, Mosby, 1973, p 164
28. Fabry ME, Nagel RL: Heterogeneity of red cells in the sickler: A characteristic with practical clinical and pathophysiological implications. Blood Cells 8:9, 1982
29. Seakins M, Gibbs WN, Milner PF, Bertles JF: Erythrocyte Hb-S concentration. An important factor in the low oxygen affinity of blood in sickle cell anemia. J Clin Invest 52:422, 1973
30. Hasegawa S, Rodgers GP, Dwyer N, Noguchi CT, Blanchette-Mackie EJ, Uyesaka N, Schechter AN, Fibach E: Sickling of nucleated erythroid precursors from patients with sickle cell anemia. Exp Med 26:314, 1998
31. Finch CA, Deubelbeiss K, Cook JD, Eschbach JW, Harker LA, Funk DD, Marsaglia G, Hillman RS, Slichter S, Adamson JW, Ganzoni A, Giblett ER: Ferrokinetics in man. Medicine 49:17, 1970
32. Bothwell TH, Charllon RW, Cook JD, Finch CA: Iron Metabolism in Man. London, UK, Blackwell Scientific, 1979, p 576
33. Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC, Davies SC, Ohene-Frempong K, Bernaudin F, Matthews DC, Storb R, Sullivan KM: Bone marrow transplantation for sickle cell disease. N Engl J Med 335:369, 1996
34. Longmore GD: Erythropoietin receptor mutations and Olympic glory. Nat Genet 4:108, 1993
35. Applebaum EL, Frankel A: Extramedullary hematopoiesis of the middle ear. Am J Otolaryngol 10:287, 1989
36. Gumbs RV, Higginbotham-Ford EA, Teal JS, Kletter GG, Castro O: Thoracic extramedullary hematopoiesis in sickle-cell disease. Am J Roentgenol 149:889, 1987
37. Verani R, Olson J, Moake JL: Intrathoracic extramedullary hematopoiesis: Report of a case in a patient with sickle-cell disease-betathalassemia (review). Am J Clin Pathol 73:133, 1980
38. Sher GD, Olivieri NF: Rapid healing of chronic leg ulcers during arginine butyrate therapy in patients with sickle cells disease and thalassemia. Blood 84:2378, 1994
39. Cotran RS, Kumar V, Robbins SL : Robbins Pathologic Basis of Disease (ed 4). Philadelphia, PA, Saunders, 1989, p 1519
40. Yam LT, Li C-Y: The spleen, in Embury SH, Hebbel RP, Mohandas N, Steinberg MH (eds): Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY, Raven, 1994, p 555
41. Fibbe WE, Hamilton MS, Laterveer LL, Kibbelaar RE, Talkenburg JHF, Visser JWM, Willenze R: Sustained engraftment of mice transplanted with IL-1-primed blood derived stem cells. J Immunol 148:417, 1992
42. Kovacs CJ, Harrell JP, Evans MJ, Abernathy RS, Roberts CJ, Johnke RM: Stem cell responses in myelosuppressed mice following sequential treatment with recombinant human interleukin 1 (rHuIL-1), recombinant murine interleukin 3 (rMuIL-3) and recombinant human macrophage colony-stimulating factor (rHuM-CSF). Stem Cells 12: 103, 1994
43. Nadeau K, Gee B, Jennette JC, Tilney N, Trudel M, Platt OS: Increased inflammatory and endothelial cell factors in tissues from humans and mice with sickle cell disease. Blood 90:125a, 1997 (abstr, suppl 1)